Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

Creative Commons License

Demir A., Mandel N., Paydas S., Demir G., Er O. , Turhal N., ...More

BALKAN MEDICAL JOURNAL, vol.37, no.2, pp.104-107, 2020 (Journal Indexed in SCI) identifier identifier identifier


Background: The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen receptor-positive metastatic breast cancer. In spite of this, the activity of CDK4/6 inhibitors in patients with metastatic breast cancer who have progressed despite receiving multiple lines of treatment is not well understood.